These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 21494615)
1. Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC PLoS One; 2011 Apr; 6(4):e18469. PubMed ID: 21494615 [TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023 [TBL] [Abstract][Full Text] [Related]
3. Nerve excitability assessment in chemotherapy-induced neurotoxicity. Park SB; Lin CS; Kiernan MC J Vis Exp; 2012 Apr; (62):. PubMed ID: 22565594 [TBL] [Abstract][Full Text] [Related]
4. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC J Clin Oncol; 2009 Mar; 27(8):1243-9. PubMed ID: 19164207 [TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin and axonal Na+ channel function in vivo. Krishnan AV; Goldstein D; Friedlander M; Kiernan MC Clin Cancer Res; 2006 Aug; 12(15):4481-4. PubMed ID: 16899592 [TBL] [Abstract][Full Text] [Related]
6. Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation. Heide R; Bostock H; Ventzel L; Grafe P; Bergmans J; Fuglsang-Frederiksen A; Finnerup NB; Tankisi H Clin Neurophysiol; 2018 Mar; 129(3):694-706. PubMed ID: 29233604 [TBL] [Abstract][Full Text] [Related]
7. Acute changes in nerve excitability following oxaliplatin treatment in mice. Makker PGS; White D; Lees JG; Parmar J; Goldstein D; Park SB; Howells J; Moalem-Taylor G J Neurophysiol; 2020 Jul; 124(1):232-244. PubMed ID: 32519566 [TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin, an anticancer agent that affects both Na+ and K+ channels in frog peripheral myelinated axons. Benoit E; Brienza S; Dubois JM Gen Physiol Biophys; 2006 Sep; 25(3):263-76. PubMed ID: 17197725 [TBL] [Abstract][Full Text] [Related]
9. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Gamelin E; Gamelin L; Bossi L; Quasthoff S Semin Oncol; 2002 Oct; 29(5 Suppl 15):21-33. PubMed ID: 12422305 [TBL] [Abstract][Full Text] [Related]
10. Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy. Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC Exp Neurol; 2011 Jan; 227(1):120-7. PubMed ID: 20965170 [TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-induced neurotoxicity and the development of neuropathy. Krishnan AV; Goldstein D; Friedlander M; Kiernan MC Muscle Nerve; 2005 Jul; 32(1):51-60. PubMed ID: 15880395 [TBL] [Abstract][Full Text] [Related]
12. Latent addition in human motor and sensory axons: different site-dependent changes across the carpal tunnel related to persistent Na+ currents. Kuwabara S; Misawa S; Tamura N; Nakata M; Kanai K; Sawai S; Ogawara K; Hattori T Clin Neurophysiol; 2006 Apr; 117(4):810-4. PubMed ID: 16497550 [TBL] [Abstract][Full Text] [Related]
14. Impact of oxaliplatin-induced neuropathy: a patient perspective. Bennett BK; Park SB; Lin CS; Friedlander ML; Kiernan MC; Goldstein D Support Care Cancer; 2012 Nov; 20(11):2959-67. PubMed ID: 22426503 [TBL] [Abstract][Full Text] [Related]
15. Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability. Kiernan MC; Krishnan AV; Lin CS; Burke D; Berkovic SF Brain; 2005 Aug; 128(Pt 8):1841-6. PubMed ID: 15857929 [TBL] [Abstract][Full Text] [Related]
16. The mechanism of the actions of oxaliplatin on ion currents and action potentials in differentiated NG108-15 neuronal cells. Wu SN; Chen BS; Wu YH; Peng H; Chen LT Neurotoxicology; 2009 Jul; 30(4):677-85. PubMed ID: 19422847 [TBL] [Abstract][Full Text] [Related]
17. Sodium channel inactivation kinetics of rat sensory and motor nerve fibres and their modulation by glutathione. Mitrović N; Quasthoff S; Grafe P Pflugers Arch; 1993 Dec; 425(5-6):453-61. PubMed ID: 8134261 [TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-induced Acute Neurotoxicity Recovers Between Repeat Infusion Cycles: An Axonal Excitability Repeated Multiple Measurements Study. Kokotis P; Papantoniou M; Carr RW; Schmelz M; Siakavella D; Skafida E; Papadimitriou C Cancer Diagn Progn; 2024; 4(3):320-325. PubMed ID: 38707730 [TBL] [Abstract][Full Text] [Related]
19. The effects of mexiletine on excitability properties of human median motor axons. Kuwabara S; Misawa S; Tamura N; Kanai K; Hiraga A; Ogawara K; Nakata M; Hattori T Clin Neurophysiol; 2005 Feb; 116(2):284-9. PubMed ID: 15661106 [TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study. Kokotis P; Schmelz M; Kostouros E; Karandreas N; Dimopoulos MA Clin Colorectal Cancer; 2016 Sep; 15(3):e133-40. PubMed ID: 27038553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]